Evoq Remedies Ltd
Evoq Remedies Ltd (EVOQ): company summary
The company's revenue rose 116.9% annually, but net profit swung from a profit of ₹0 crore to a loss of ₹0 crore.
Evoq Remedies Ltd (EVOQ) is a micro-cap Commercial Services company valued at ₹5 crore operating in Trading & Distributors on the NSE and BSE.
- Recent price move
- Evoq Remedies Ltd last traded at ₹1.95, up 3.72% on the day.
- Financial performance
- The company's revenue rose 116.9% annually, but net profit swung from a profit of ₹0 crore to a loss of ₹0 crore. The latest quarter saw revenue drop 100.0% compared to the same quarter a year earlier, and net profit swung from a profit of ₹2 crore to a loss of ₹0 crore.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.09 times book value.
- Things to watch
- The company reported a net loss of ₹0 crore in its latest financial year, and the net profit margin fell to -0.9% from 0.3% the prior year. The latest quarter's revenue collapsed 100.0% compared to the same quarter a year earlier, and net profit swung to a loss of ₹0 crore from a profit of ₹2 crore.
- Where it stands
- EVOQ Remedies Ltd ended its latest financial year with a net loss of ₹0 crore, while revenue grew 116.9% annually. The latest quarter's revenue fell 100.0% compared to the same quarter a year earlier, and net profit swung to a loss of ₹0 crore from a profit of ₹2 crore.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and valuation (6.0), but held back by momentum (0.0). Growth looks strong at 7.5, but that is offset by momentum at 0.0 and quality at 1.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.00
- Revenue compounding 21% a year
- Loss-making — no meaningful P/E
- Quality is weak (1.5/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Commercial Services stocks · Trading & Distributors
Explore Evoq Remedies Ltd’s valuation
Free deep-dive tools · no sign-up
Evoq Remedies Ltd peers in Commercial Services
Other Commercial Services stocks on the NSE & BSE. See the full Commercial Services sector list.
Related tools & concepts
Value Evoq Remedies Ltd with the ratios and calculators DocStoX uses in its analysis.

